C4 Therapeutics, Inc. (CCCC)

SEC filing

C4 Therapeutics, Inc.

CCCC · CIK 1662579

4 · Jan 5, 2026 · Anderson Kenneth Carl was granted 5,958 shares at $1.93/share ($11,499)

Anderson Kenneth Carl was granted 5,958 shares at $1.93/share ($11,499)

FORM 4

xslF345X05/wk-form4_1767647442.xmlSEC.gov

c4therapeutics-section16.htm

c4therapeutics-section16.htmSEC.gov

Graphics and non-inline formats (not embedded below).